Core Viewpoint - The company, Yidu Tech (02158.HK), announced a share buyback on December 8, 2023, spending HKD 1.178 million to repurchase 225,000 shares at a price range of HKD 5.21 to 5.25 per share [1]. Summary by Category - **Company Actions** - Yidu Tech executed a buyback of 225,000 shares at a total cost of HKD 1.178 million [1]. - The repurchase price per share ranged from HKD 5.21 to HKD 5.25 [1].

智通财经APP讯，医渡科技(02158)发布公告，于2025年12月8日，该公司斥资117.82万港元回购22.5万股 股份，每股回购价5.21-5.25港元。 ...

医渡科技(02158)发布公告，于2025年12月8日，该公司斥资117.82万港元回购22.5万股股份，每股回购 价5.21-5.25港元。 ...

FF305 翌日披露報表 (股份發行人 ── 已發行股份或庫存股份變動、股份購回及/或在場内出售庫存股份) 表格類別： 股票 狀態： 新提交 公司名稱： 醫渡科技有限公司 呈交日期： 2025年12月8日 如上市發行人的已發行股份或庫存股份出現變動而須根據《香港聯合交易所有限公司（「香港聯交所」）證券上市規則》(「《主板上市規則》」)第13.25A條 / 《香港聯合交易所有限公司GEM證券 上市規則》(「《GEM上市規則》」)第17.27A條作出披露，必須填妥第一章節 。 | 第一章節 | | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | 於香港聯交所上市 | 是 | | | | 證券代號 (如上市) | 02158 | 說明 | | | | | | | | A. 已發行股份或庫存股份變動 | | | | | | | | | | | | | 已發行股份（不包括庫存股份）變動 | | 庫存股份變動 | | | | | | 事件 | 已發行股份（不包括庫存 ...

Group 1 - The core viewpoint of the article highlights that Yidu Tech (02158) has been actively repurchasing shares for three consecutive days, signaling positive market sentiment [1] - On December 5, the company repurchased 280,000 shares at a price of HKD 5.18 per share, totaling HKD 1.4 million, bringing the total repurchased shares to approximately 853,000 and the cumulative repurchase amount to over HKD 4.3 million [1] - Yidu Tech reported a healthy revenue growth for the fiscal year 2026, with total revenue reaching RMB 358 million, representing a year-on-year increase of 8.7% [1] Group 2 - The company achieved a significant milestone in profitability, with adjusted EBITDA from existing operations reaching approximately RMB 54 million, doubling compared to the same period last year, and nearing breakeven on the financial statements [1] - This key financial milestone was achieved approximately one year ahead of the management's previous expectations [1] - Yidu Tech has officially launched a digital technology research and development platform in collaboration with Tsinghua Changgung Hospital, marking a new phase in their partnership in the field of medical artificial intelligence [1]

Group 1 - The core viewpoint of the article highlights that Yidu Technology (02158) has been actively repurchasing its shares for three consecutive days, signaling positive market sentiment [1] - The company repurchased 280,000 shares at a price of HKD 5.18 per share on December 5, with a total repurchase amount of HKD 1.4 million, bringing the total shares repurchased to approximately 853,000 and the cumulative repurchase amount exceeding HKD 4.3 million [1] - Yidu Technology reported a healthy revenue growth for the fiscal year 2026, achieving total revenue of RMB 358 million, which represents a year-on-year increase of 8.7% [1] Group 2 - The adjusted EBITDA for existing business reached approximately RMB 54 million, doubling compared to the same period last year, indicating significant improvement in profitability and operational efficiency [1] - The company has nearly reached breakeven on its financial statements, achieving this key financial milestone about a year earlier than previously anticipated by management [1] - A new collaboration has been initiated between Yidu Technology and Tsinghua Changgung Hospital to establish a digital technology research and development platform, marking a new phase in their partnership in the field of medical artificial intelligence [1]

Core Viewpoint - The company, Yidu Tech (02158.HK), announced a share buyback on December 5, 2023, spending HKD 1.45 million to repurchase 280,000 shares at a price range of HKD 5.15 to 5.20 per share [1] Group 1 - The total expenditure for the share buyback was HKD 1.45 million [1] - The number of shares repurchased was 280,000 [1] - The price range for the repurchased shares was between HKD 5.15 and HKD 5.20 [1]

智通财经APP讯，医渡科技(02158)发布公告，该公司于2025年12月5日斥资145.12万港元回购28万股股 份，每股回购价格为5.15-5.2港元。 ...

FF305 翌日披露報表 (股份發行人 ── 已發行股份或庫存股份變動、股份購回及/或在場内出售庫存股份) 表格類別： 股票 狀態： 新提交 公司名稱： 醫渡科技有限公司 呈交日期： 2025年12月5日 如上市發行人的已發行股份或庫存股份出現變動而須根據《香港聯合交易所有限公司（「香港聯交所」）證券上市規則》(「《主板上市規則》」)第13.25A條 / 《香港聯合交易所有限公司GEM證券 上市規則》(「《GEM上市規則》」)第17.27A條作出披露，必須填妥第一章節 。 | 第一章節 | | | | | | | | --- | --- | --- | --- | --- | --- | --- | | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | 於香港聯交所上市 | 是 | | | 證券代號 (如上市) | 02158 | 說明 | | | | | | A. 已發行股份或庫存股份變動 | | | | | | | | | 事件 | | 已發行股份（不包括庫存股份）變動 | 庫存股份變動 | 每股發行/出售價 (註4) | 已發行股份總數 | | | | 已發行股份（不包括庫存股份）數 目 | 佔 ...

Group 1 - Company announced a share buyback of 181,000 shares at a cost of HKD 931,600 on December 4, 2025 [2][4]